Clinical trials
Observational Thyroid Neoplasms trials in Italy
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
26 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2008 | 1 |
| 2010 | 2 |
| 2012 | 2 |
| 2013 | 1 |
| 2014 | 1 |
| 2018 | 1 |
| 2021 | 2 |
| 2022 | 6 |
| 2023 | 5 |
| 2024 | 1 |
| 2025 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 9 |
| Recruiting | 8 |
| Unknown status | 5 |
| Not yet recruiting | 1 |
| Enrolling by invitation | 1 |
| Terminated | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| IRCCS Azienda Ospedaliero-Universitaria di Bologna | 3 |
| Istituto Auxologico Italiano | 3 |
| University of Cagliari | 3 |
| Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 2 |
| IRCCS San Raffaele | 2 |
| University of Roma La Sapienza | 2 |
| Azienda Ospedaliera di Padova | 1 |
| Genzyme, a Sanofi Company | 1 |
| IRCCS SYNLAB SDN | 1 |
| National Cancer Institute, Naples | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Thyroid Neoplasms | 26 |
| Thyroid Diseases | 5 |
| Carcinoma, Medullary | 2 |
| Hyperthyroidism | 2 |
| Neoplasms | 2 |
| Thyroid Cancer, Papillary | 2 |
| Thyroid Carcinoma, Anaplastic | 2 |
| Thyroid Nodule | 2 |
| Adenocarcinoma, Follicular | 1 |
| Adrenal Cortex Neoplasms | 1 |
Trials
Showing 1 to 25 of 26. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.